Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Глобальное бремя артериальной гипертензии и систолического артериального давления не менее 110–115 мм рт. ст., 1990–2015 гг.
2017-01-10
SCID: 54.1/ennkuv2x
Discuss with AI
comparative risk assessmentdisability-adjusted life yearsglobal burden of diseasespatiotemporal Gaussian process regressionsystolic blood pressure
Figures from the paper
Abstract (AI)
Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. Main Outcomes and Measures: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year. Results: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. Conclusions and Relevance: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.
Key Findings
1
Annual deaths associated with SBP at least 110–115 mm Hg increased from 135.6 to 145.2 per 100,000, while deaths associated with SBP at least 140 mm Hg increased from 97.9 to 106.3 per 100,000.
2
DALYs associated with SBP at least 140 mm Hg increased from 95.9 million to 143.0 million between 1990 and 2015, indicating a growing global health burden.
3
The global prevalence of SBP at least 110–115 mm Hg increased from 73,119 to 81,373 per 100,000 between 1990 and 2015.
4
The global prevalence of SBP at least 140 mm Hg increased from 17,307 to 20,526 per 100,000 over the same period.
5
Using 844 studies involving 8.69 million participants, the analysis estimated systolic blood pressure distributions and attributable health burdens across 195 countries and territories from 1990 to 2015.
Research Object
Global populations across 195 countries and territories, characterized by systolic blood pressure (SBP) levels from 1990 to 2015
Research Subject
Age-, sex-, country-, and year-specific associations of SBP thresholds (≥110–115 mm Hg and ≥140 mm Hg) with cause-specific mortality and disability burden
Publication Details
Publication Date
2017-01-10
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults2013
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015